Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0002060755-25-000012
Filing Date
2025-05-14
Accepted
2025-05-13 19:16:15
Documents
3
Period of Report
2025-05-13

Document Format Files

Seq Description Document Type Size
1 f6k-20250513.htm 6-K 4959
2 NEWS RELEASE ex991-20250513.htm EX-99.1 13388
3 ex99120250513_1.jpg GRAPHIC 2579
  Complete submission text file 0002060755-25-000012.txt   23039
Mailing Address 19 VESTRY STREET NEW YORK NY 10013
Business Address 19 VESTRY STREET NEW YORK NY 10013 6474072515
BRIGHT MINDS BIOSCIENCES INC. (Filer) CIK: 0001827401 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
Type: 6-K | Act: 34 | File No.: 001-40997 | Film No.: 25942078
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)